An Open-Label Phase II Study to Evaluate Immunogenicity and Safety of a Single IMVAMUNE Booster Vaccination Two Years After the Last IMVAMUNE Vaccination in Former POX-MVA-005 Vaccinees

This study has been completed.
National Institute of Allergy and Infectious Diseases (NIAID)
Information provided by:
Bavarian Nordic Identifier:
First received: May 27, 2008
Last updated: May 21, 2010
Last verified: May 2010
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2009
  Primary Completion Date: July 2009 (Final data collection date for primary outcome measure)